Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Remyelination in experimental models of toxin-induced demyelination.
Episode 58 with Dr. Gavin Giovannoni on the new MS Brain Health initiative
2015 Annual Meeting of the Consortium of the Multiple Sclerosis Centers
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
Transfer of interferon β-1a into human breastmilk.
EAE: an immunologist's magic eye.
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Scientific discussion for the approval of Masivet
ECTRIMS 2015
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
National MS Society: Postdoctoral Fellowships
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
ACTRIMS-ECTRIMS 2014 -- Day 1, afternoon
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.

Pages